Building on momentum from positive diabetes data, Zafgen scoops Biogen alum Priya Singhal as head of R&D
On the heels of some positive mid-stage data on its lead diabetes drug, Zafgen $ZFGN has brought in seasoned biotech exec Priya Singhal to steering …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
